Cargando…
When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma
BACKGROUND: Living donor liver transplantation (LDLT) is an acceptable treatment option for hepatocellular carcinoma (HCC). Traditional transplant criteria aim at best utilization of donor organs with low risk of post transplant recurrence. In LDLT, long term recurrence free survival (RFS) of 50% is...
Autores principales: | Bhatti, Abu Bakar Hafeez, Qureshi, Ammal Imran, Tahir, Rizmi, Dar, Faisal Saud, Khan, Nusrat Yar, Zia, Haseeb Haider, Riyaz, Shahzad, Rana, Atif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425141/ https://www.ncbi.nlm.nih.gov/pubmed/32787864 http://dx.doi.org/10.1186/s12885-020-07238-w |
Ejemplares similares
-
Living donor liver transplantation for intra hepatic cholangiocarcinoma
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2020) -
Liver transplantation for hepatocellular carcinoma: Improving eligibility without compromising outcomes
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2021) -
Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021) -
Living Donor Liver Transplantation During the COVID-19 Pandemic: an Evolving Challenge
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021) -
Survival after extended resections for gallbladder cancer
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2023)